Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies.

Published

Journal Article (Review)

Stereotactic body radiation therapy (SBRT) has become the preferred treatment approach for patients with stage I non-small cell lung cancer who are medically inoperable or refuse surgery. SBRT consists of 3 to 5 radiation treatments delivered over a 10- to 14-day period. Local control is achieved in approximately 90% of patients, and the risk of toxicity is relatively low. Ongoing studies are examining whether SBRT can replace surgery for certain patients, the optimal dose-fractionation scheme, and how best to treat patients having central tumors near the primary tracheobronchial tree.

Full Text

Duke Authors

Cited Authors

  • Kelsey, CR; Salama, JK

Published Date

  • July 2013

Published In

Volume / Issue

  • 22 / 3

Start / End Page

  • 463 - 481

PubMed ID

  • 23622074

Pubmed Central ID

  • 23622074

Electronic International Standard Serial Number (EISSN)

  • 1558-5042

Digital Object Identifier (DOI)

  • 10.1016/j.soc.2013.02.011

Language

  • eng

Conference Location

  • United States